{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:07:38Z","timestamp":1784092058014,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Liaoning province Natural Science Project of Education Department","award":["LJ21251016201"],"award-info":[{"award-number":["LJ21251016201"]}]},{"name":"Public Health Research and Development Project, Shenyang Science and Technology Bureau","award":["22-321-34-04"],"award-info":[{"award-number":["22-321-34-04"]}]},{"name":"Liaoning Province Basic scientific research project of Education Department","award":["JYTMS20231819"],"award-info":[{"award-number":["JYTMS20231819"]}]},{"name":"Clinical collaboration project of traditional Chinese and western medicine for major and difficult diseases","award":["XDYN-2024-A-123"],"award-info":[{"award-number":["XDYN-2024-A-123"]}]},{"name":"Liaoning Provincial Science and Technology Program Joint Project","award":["2024JH2\/102600200"],"award-info":[{"award-number":["2024JH2\/102600200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05053-2","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:07:10Z","timestamp":1779350830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of vascular lesions in immunoglobulin a nephropathy: a meta-analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Zhihan","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"1","key":"5053_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","volume":"9","author":"E Stamellou","year":"2023","unstructured":"Stamellou E, Seikrit C, Tang SCW, Boor P, Tesa\u0159 V, Floege J, et al. IgA nephropathy. Nat Rev Dis Primers. 2023;9(1):67. https:\/\/doi.org\/10.1038\/s41572-023-00476-9.","journal-title":"Nat Rev Dis Primers"},{"issue":"4s","key":"5053_CR2","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","year":"2024","unstructured":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4s):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"2","key":"5053_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ndt\/gfq665","volume":"26","author":"A McGrogan","year":"2011","unstructured":"McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transpl. 2011;26(2):414\u201330. https:\/\/doi.org\/10.1093\/ndt\/gfq665.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"5053_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/cjn.0000000000000135","volume":"18","author":"D Pitcher","year":"2023","unstructured":"Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. Long-Term Outcomes in IgA Nephropathy. Clin J Am Soc Nephrol. 2023;18(6):727\u201338. https:\/\/doi.org\/10.2215\/cjn.0000000000000135.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"5053_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1681\/asn.2018101017","volume":"30","author":"S Jarrick","year":"2019","unstructured":"Jarrick S, Lundberg S, Welander A, Carrero JJ, H\u00f6ijer J, Bottai M, et al. Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study. J Am Soc Nephrol. 2019;30(5):866\u201376. https:\/\/doi.org\/10.1681\/asn.2018101017.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5053_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12882-025-03958-y","volume":"26","author":"M Rivedal","year":"2025","unstructured":"Rivedal M, Nordb\u00f8 OP, Haaskjold YL, Bj\u00f8rneklett R, Knoop T, Eikrem \u00d8. Lifetime progression of IgA nephropathy: a retrospective cohort study with extended long-term follow-up. BMC Nephrol. 2025;26(1):32. https:\/\/doi.org\/10.1186\/s12882-025-03958-y.","journal-title":"BMC Nephrol"},{"issue":"2","key":"5053_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.ajkd.2023.12.016","volume":"84","author":"C Tang","year":"2024","unstructured":"Tang C, Chen P, Si FL, Lv JC, Shi SF, Zhou XJ, et al. Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study. Am J Kidney Dis. 2024;84(2):170\u2013e81. https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.016.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"5053_CR8","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/ndt\/gfaf084","volume":"40","author":"JJ Sim","year":"2025","unstructured":"Sim JJ, Chen Q, Cannizzaro N, Fernandes AW, Pinto C, Bhandari SK, et al. CKD progression, kidney failure, and mortality among US patients with IgA nephropathy. Nephrol Dial Transpl. 2025;40(11):2104\u201317. https:\/\/doi.org\/10.1093\/ndt\/gfaf084.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"5053_CR9","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014\u201321. https:\/\/doi.org\/10.1016\/j.kint.2017.02.003.","journal-title":"Kidney Int"},{"issue":"4","key":"5053_CR10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2014.63","volume":"86","author":"R Coppo","year":"2014","unstructured":"Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86(4):828\u201336. https:\/\/doi.org\/10.1038\/ki.2014.63.","journal-title":"Kidney Int"},{"issue":"2","key":"5053_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/ajkd.2000.8966","volume":"36","author":"G D\u2019Amico","year":"2000","unstructured":"D\u2019Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis. 2000;36(2):227\u201337. https:\/\/doi.org\/10.1053\/ajkd.2000.8966.","journal-title":"Am J Kidney Dis"},{"key":"5053_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejim.2023.07.007","volume":"117","author":"Y Ruan","year":"2023","unstructured":"Ruan Y, Hong F, Lin M, Wang C, Lian F, Cao F, et al. Clinicopathological characteristics, risk factors and prognostic value of intrarenal vascular lesions in IgA nephropathy. Eur J Intern Med. 2023;117:91\u20137. https:\/\/doi.org\/10.1016\/j.ejim.2023.07.007.","journal-title":"Eur J Intern Med"},{"issue":"12","key":"5053_CR13","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.numecd.2020.07.038","volume":"30","author":"E Russo","year":"2020","unstructured":"Russo E, Drovandi S, Salvidio G, Verzola D, Esposito P, Garibotto G, et al. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy. Nutr Metab Cardiovasc Dis. 2020;30(12):2343\u201350. https:\/\/doi.org\/10.1016\/j.numecd.2020.07.038.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"5053_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0272-6386(12)80595-6","volume":"15","author":"R Katafuchi","year":"1990","unstructured":"Katafuchi R, Vamvakas E, Neelakantappa K, Baldwin DS, Gallo GR. Microvascular disease and the progression of IgA nephropathy. Am J Kidney Dis. 1990;15(1):72\u20139. https:\/\/doi.org\/10.1016\/s0272-6386(12)80595-6.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5053_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/nep.12339","volume":"20","author":"C Bazzi","year":"2015","unstructured":"Bazzi C, Stivali G, Rachele G, Rizza V, Casellato D, Nangaku M. Arteriolar hyalinosis and arterial hypertension as possible surrogate markers of reduced interstitial blood flow and hypoxia in glomerulonephritis. Nephrol (Carlton). 2015;20(1):11\u20137. https:\/\/doi.org\/10.1111\/nep.12339.","journal-title":"Nephrol (Carlton)"},{"issue":"5","key":"5053_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"DC Cattran","year":"2009","unstructured":"Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534\u201345. https:\/\/doi.org\/10.1038\/ki.2009.243.","journal-title":"Kidney Int"},{"key":"5053_CR17","doi-asserted-by":"publisher","unstructured":"Soares J, Carnevale A, Ramos ARP, Almeida R, Borges M, Caeiro F, et al. #3697 Integrating crescent characteristics, vascular lesions, and podocyte injury into the MEST-C framework: enhanced risk stratification in IgA nephropathy. Nephrol Dial Transplant. 2025;40(Suppl 3). https:\/\/doi.org\/10.1093\/ndt\/gfaf116.0305.","DOI":"10.1093\/ndt\/gfaf116.0305"},{"key":"5053_CR18","doi-asserted-by":"publisher","unstructured":"Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Fr\u00e9meaux-Bacchi V, Kavanagh D, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017;91(3):539\u2009\u2013\u200951. https:\/\/doi.org\/10.1016\/j.kint.2016.10.005.","DOI":"10.1016\/j.kint.2016.10.005"},{"issue":"5","key":"5053_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.mpdhp.2013.02.004","volume":"19","author":"A Chang","year":"2013","unstructured":"Chang A. Thrombotic microangiopathy and the kidney: a nephropathologist\u2019s perspective. Diagn Histopathology. 2013;19(5):158\u201365. https:\/\/doi.org\/10.1016\/j.mpdhp.2013.02.004.","journal-title":"Diagn Histopathology"},{"issue":"7\u20138","key":"5053_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000531693","volume":"54","author":"P Puapatanakul","year":"2023","unstructured":"Puapatanakul P, Banjongjit A, Kanjanabuch T, Surintrspanont J, Iampenkhae K, Praditpornsilpa K, et al. Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand. Am J Nephrol. 2023;54(7\u20138):308\u201318. https:\/\/doi.org\/10.1159\/000531693.","journal-title":"Am J Nephrol"},{"key":"5053_CR21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"9","key":"5053_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"5053_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3102\/10769986030003261","volume":"30","author":"W Viechtbauer","year":"2005","unstructured":"Viechtbauer W. Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educational Behav Stat. 2005;30(3):261\u201393. https:\/\/doi.org\/10.3102\/10769986030003261.","journal-title":"J Educational Behav Stat"},{"issue":"5","key":"5053_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.ajkd.2019.03.416","volume":"74","author":"Q Cai","year":"2019","unstructured":"Cai Q, Shi S, Wang S, Ren Y, Hou W, Liu L, et al. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study. Am J Kidney Dis. 2019;74(5):629\u201339. https:\/\/doi.org\/10.1053\/j.ajkd.2019.03.416.","journal-title":"Am J Kidney Dis"},{"key":"5053_CR25","doi-asserted-by":"publisher","first-page":"761897","DOI":"10.3389\/fmed.2021.761897","volume":"8","author":"L Dong","year":"2021","unstructured":"Dong L, Tan J, Li F, Wang S, Jiang Z, Qin A, et al. Arterial-Arteriolar Sclerosis Is Independently Associated With Poor Renal Outcome in IgA Nephropathy Patients. Front Med (Lausanne). 2021;8:761897. https:\/\/doi.org\/10.3389\/fmed.2021.761897.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"5053_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1159\/000489290","volume":"43","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Sun L, Zhou S, Xu Q, Xu Q, Liu D, et al. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy. Kidney Blood Press Res. 2018;43(2):639\u201350. https:\/\/doi.org\/10.1159\/000489290.","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"5053_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12882-024-03803-8","volume":"25","author":"HT Yang","year":"2024","unstructured":"Yang HT, Park TI, Kim YJ, Kim MS, Park SH, Lim JH, et al. Significance of intrarenal vascular lesions in Ig A nephropathy prognosis. BMC Nephrol. 2024;25(1):355. https:\/\/doi.org\/10.1186\/s12882-024-03803-8.","journal-title":"BMC Nephrol"},{"issue":"4","key":"5053_CR28","doi-asserted-by":"publisher","first-page":"e0320635","DOI":"10.1371\/journal.pone.0320635","volume":"20","author":"Q Wu","year":"2025","unstructured":"Wu Q, Chen Y, Shen M, Cai Y, Yu H, Zhou L, et al. Moderate to severe chronic arteriolar lesions is an independent risk factor for adverse renal outcomes in IgA nephropathy. PLoS ONE. 2025;20(4):e0320635. https:\/\/doi.org\/10.1371\/journal.pone.0320635.","journal-title":"PLoS ONE"},{"issue":"1","key":"5053_CR29","doi-asserted-by":"publisher","first-page":"2476052","DOI":"10.1080\/0886022x.2025.2476052","volume":"47","author":"J Tu","year":"2025","unstructured":"Tu J, Chen X, Yang H, Zuo Y, Li F, Zhang J, et al. Impact of intrarenal arterial lesions on prognosis of IgA nephropathy: insights from a retrospective cohort study. Ren Fail. 2025;47(1):2476052. https:\/\/doi.org\/10.1080\/0886022x.2025.2476052.","journal-title":"Ren Fail"},{"issue":"6","key":"5053_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/cjp2.234","volume":"7","author":"N Sugiura","year":"2021","unstructured":"Sugiura N, Moriyama T, Miyabe Y, Karasawa K, Nitta K. Severity of arterial and\/or arteriolar sclerosis in IgA nephropathy and the effects of renin-angiotensin system inhibitors on its prognosis. J Pathol Clin Res. 2021;7(6):616\u201323. https:\/\/doi.org\/10.1002\/cjp2.234.","journal-title":"J Pathol Clin Res"},{"issue":"1","key":"5053_CR31","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/0886022x.2022.2083974","volume":"44","author":"Y Shen","year":"2022","unstructured":"Shen Y, Xiao T, Yu Z, Huang Y, He T, Li H, et al. Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy. Ren Fail. 2022;44(1):994\u20131003. https:\/\/doi.org\/10.1080\/0886022x.2022.2083974.","journal-title":"Ren Fail"},{"issue":"11","key":"5053_CR32","doi-asserted-by":"publisher","first-page":"e0233199","DOI":"10.1371\/journal.pone.0233199","volume":"15","author":"P Neves","year":"2020","unstructured":"Neves P, Souza RA, Torres FM, Reis FA, Pinheiro RB, Dias CB, et al. Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy. PLoS ONE. 2020;15(11):e0233199. https:\/\/doi.org\/10.1371\/journal.pone.0233199.","journal-title":"PLoS ONE"},{"issue":"4","key":"5053_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10157-015-1185-0","volume":"20","author":"Y Kaneko","year":"2016","unstructured":"Kaneko Y, Yoshita K, Kono E, Ito Y, Imai N, Yamamoto S, et al. Extracapillary proliferation and arteriolar hyalinosis are associated with long-term kidney survival in IgA nephropathy. Clin Exp Nephrol. 2016;20(4):569\u201377. https:\/\/doi.org\/10.1007\/s10157-015-1185-0.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"5053_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40620-022-01511-w","volume":"36","author":"Z Huang","year":"2023","unstructured":"Huang Z, Hu Y, Chen B, Liang Y, Li D, Qiu W, et al. Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy. J Nephrol. 2023;36(2):429\u201340. https:\/\/doi.org\/10.1007\/s40620-022-01511-w.","journal-title":"J Nephrol"},{"issue":"1","key":"5053_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/asn.2010111130","volume":"23","author":"K El Karoui","year":"2012","unstructured":"El Karoui K, Hill GS, Karras A, Jacquot C, Moulonguet L, Kourilsky O, et al. A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol. 2012;23(1):137\u201348. https:\/\/doi.org\/10.1681\/asn.2010111130.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5053_CR36","doi-asserted-by":"publisher","first-page":"sfae012","DOI":"10.1093\/ckj\/sfae012","volume":"17","author":"L Dong","year":"2024","unstructured":"Dong L, Hu Y, Yang D, Liu L, Li Y, Ge S, et al. Microangiopathy associated with poor outcome of immunoglobulin A nephropathy: a cohort study and meta-analysis. Clin Kidney J. 2024;17(2):sfae012. https:\/\/doi.org\/10.1093\/ckj\/sfae012.","journal-title":"Clin Kidney J"},{"issue":"8","key":"5053_CR37","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41379-019-0259-z","volume":"32","author":"JS Chua","year":"2019","unstructured":"Chua JS, Zandbergen M, Wolterbeek R, Baelde HJ, van Es LA, de Fijter JW, et al. Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis. Mod Pathol. 2019;32(8):1147\u201357. https:\/\/doi.org\/10.1038\/s41379-019-0259-z.","journal-title":"Mod Pathol"},{"issue":"5","key":"5053_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41440-018-0026-4","volume":"41","author":"N Ohashi","year":"2018","unstructured":"Ohashi N, Isobe S, Matsuyama T, Ishigaki S, Tsuji N, Fujikura T, et al. Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients. Hypertens Res. 2018;41(5):334\u201341. https:\/\/doi.org\/10.1038\/s41440-018-0026-4.","journal-title":"Hypertens Res"},{"issue":"6","key":"5053_CR39","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.ekir.2022.03.028","volume":"7","author":"J Li","year":"2022","unstructured":"Li J, Guo L, Shi S, Zhou X, Zhu L, Liu L, et al. The Role of Complement in Microangiopathic Lesions of IgA Nephropathy. Kidney Int Rep. 2022;7(6):1219\u201328. https:\/\/doi.org\/10.1016\/j.ekir.2022.03.028.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"5053_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/ndt\/gfh716","volume":"20","author":"J Wu","year":"2005","unstructured":"Wu J, Chen X, Xie Y, Yamanaka N, Shi S, Wu D, et al. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transpl. 2005;20(4):719\u201327. https:\/\/doi.org\/10.1093\/ndt\/gfh716.","journal-title":"Nephrol Dial Transpl"},{"key":"5053_CR41","doi-asserted-by":"publisher","first-page":"945913","DOI":"10.3389\/fmed.2022.945913","volume":"9","author":"WY Guo","year":"2022","unstructured":"Guo WY, An XP, Sun LJ, Dong HR, Cheng WR, Ye N, et al. Overactivation of the complement system may be involved in intrarenal arteriolar lesions in IgA nephropathy. Front Med (Lausanne). 2022;9:945913. https:\/\/doi.org\/10.3389\/fmed.2022.945913.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"5053_CR42","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1440-1797.2008.00983.x","volume":"13","author":"JJ Zhang","year":"2008","unstructured":"Zhang JJ, Jiang L, Liu G, Wang SX, Zou WZ, Zhang H, et al. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions. Nephrol (Carlton). 2008;13(8):712\u201320. https:\/\/doi.org\/10.1111\/j.1440-1797.2008.00983.x.","journal-title":"Nephrol (Carlton)"},{"issue":"5","key":"5053_CR43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.ki.5000163","volume":"69","author":"GS Hill","year":"2006","unstructured":"Hill GS, Heudes D, Jacquot C, Gauthier E, Bari\u00e9ty J. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int. 2006;69(5):823\u201331. https:\/\/doi.org\/10.1038\/sj.ki.5000163.","journal-title":"Kidney Int"},{"issue":"9","key":"5053_CR44","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/ndt\/gfac204","volume":"37","author":"Y Makita","year":"2022","unstructured":"Makita Y, Suzuki H, Nakano D, Yanagawa H, Kano T, Novak J, et al. Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries. Nephrol Dial Transpl. 2022;37(9):1629\u201336. https:\/\/doi.org\/10.1093\/ndt\/gfac204.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"5053_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5414\/cn110669","volume":"97","author":"M Huang","year":"2022","unstructured":"Huang M, Li X, Zhao L, Ding H, Liu J, Zhu L, et al. Endothelial injury by circulating IgA1 complex through the activation of mesangial cells in IgA nephropathy. Clin Nephrol. 2022;97(3):173\u201382. https:\/\/doi.org\/10.5414\/cn110669.","journal-title":"Clin Nephrol"},{"issue":"4","key":"5053_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/ndt\/gfz241","volume":"36","author":"H Trimarchi","year":"2021","unstructured":"Trimarchi H, Coppo R. Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy. Nephrol Dial Transpl. 2021;36(4):581\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfz241.","journal-title":"Nephrol Dial Transpl"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05053-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05053-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05053-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:38:29Z","timestamp":1784090309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05053-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5053"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05053-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"428"}}